| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3267 |
| Trial ID | NCT05645601 |
| Disease | Hematologic Cancer |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | JD010 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CAR-NK Targeted CD19 for r/r B-cell Malignancies |
| Year | 2022 |
| Country | China |
| Company sponsor | Affiliated Hospital to Academy of Military Medical Sciences |
| Other ID(s) | CAR-NK-JD010 |
| Cohort 1 | |||||||||||||
|
|||||||||||||